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Abstract 
Background: Mortality rates for patients with ARDS remain high. We assessed temporal changes in the epidemiol‑
ogy and management of ARDS patients requiring invasive mechanical ventilation in European ICUs. We also investi‑
gated the association between ventilatory settings and outcome in these patients.
Methods: This was a post hoc analysis of two cohorts of adult ICU patients admitted between May 1–15, 2002 (SOAP 
study, n = 3147), and May 8–18, 2012 (ICON audit, n = 4601 admitted to ICUs in the same 24 countries as the SOAP 
study). ARDS was defined retrospectively using the Berlin definitions. Values of tidal volume, PEEP, plateau pressure, 
and  FiO2 corresponding to the most abnormal value of arterial  PO2 were recorded prospectively every 24 h. In both 
studies, patients were followed for outcome until death, hospital discharge or for 60 days.
Results: The frequency of ARDS requiring mechanical ventilation during the ICU stay was similar in SOAP and ICON 
(327[10.4%] vs. 494[10.7%], p = 0.793). The diagnosis of ARDS was established at a median of 3 (IQ: 1–7) days after 
admission in SOAP and 2 (1–6) days in ICON. Within 24 h of diagnosis, ARDS was mild in 244 (29.7%), moderate in 388 
(47.3%), and severe in 189 (23.0%) patients. In patients with ARDS, tidal volumes were lower in the later (ICON) than 
in the earlier (SOAP) cohort. Plateau and driving pressures were also lower in ICON than in SOAP. ICU (134[41.1%] vs 
179[36.9%]) and hospital (151[46.2%] vs 212[44.4%]) mortality rates in patients with ARDS were similar in SOAP and 
ICON. High plateau pressure (> 29  cmH2O) and driving pressure (> 14  cmH2O) on the first day of mechanical ventila‑
tion but not tidal volume (> 8 ml/kg predicted body weight [PBW]) were independently associated with a higher risk 
of in‑hospital death.
Conclusion: The frequency of and outcome from ARDS remained relatively stable between 2002 and 2012. Plateau 
pressure > 29  cmH2O and driving pressure > 14  cmH2O on the first day of mechanical ventilation but not tidal volume 
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Introduction
The first formal description of acute respiratory distress 
syndrome (ARDS) dates back to 1967 [1]; however, it was 
only in 1994 that a broad consensus to define this com-
plex syndrome was achieved [2]. These definitions were 
widely adopted by clinicians and researchers over the 
subsequent two decades. In 2012, however, a new defi-
nition of ARDS, the Berlin definition, was developed to 
address some of the limitations of the earlier definition 
[3].
Several aspects related to the management of patients 
with ARDS have changed over the last few decades, 
including use of lung protective ventilation [4], prone 
positioning [5], and extracorporeal membrane oxygena-
tion (ECMO) [6, 7]. Despite these changes in patient 
management and respiratory support, ARDS is still asso-
ciated with mortality rates between 40 and 60% and rep-
resents a high burden on intensive care resources [8]. 
Although several studies have assessed the epidemiology 
of, outcome from, and patterns of respiratory support in 
patients with ARDS [8–13], temporal changes have not 
been widely reported [14, 15] because of the use of differ-
ent definitions and the considerable heterogeneity among 
cohorts. However, assessment of these changes is impor-
tant to understand the evolution of the burden of the dis-
ease overtime and to trace the effects of possible changes 
in clinical practice.
Importantly, mechanical ventilation, the main pil-
lar in the management of patients with ARDS, has been 
recognized as a possible cause of lung damage or venti-
lator-induced lung injury (VILI), which may have a nega-
tive impact on outcome [16, 17]. Accumulating evidence 
suggests that adopting a lung-protective strategy [4], by 
implementing low tidal volume, low plateau pressure, and 
titrated positive end-expiratory pressure (PEEP), does 
not per se preclude the development of VILI [18–21]. 
Assessment of the possible impact of ventilatory parame-
ters on outcome may help in developing new approaches 
that may minimize VILI and improve survival.
In this post-hoc analysis, we tested the hypothesis that 
management of ARDS would change over time, espe-
cially with respect to ventilator settings, including driv-
ing pressure, which would have an impact on outcome in 
patients with ARDS. We therefore first assessed temporal 
changes in the epidemiology and management of ARDS 
requiring mechanical ventilation in European intensive 
care units (ICUs) included in two large observational 
studies, performed in 2002 (SOAP study) [22] and 2012 
(ICON audit) [23], and second investigated the possible 
association between ventilatory settings on the first day 
of ARDS and outcome.
Methods
This was a post hoc analysis of two multicenter Euro-
pean cohorts. The SOAP study was conducted in 24 
European countries and included 3147 patients [22]. The 
ICON audit included 10,069 patients from 82 countries 
worldwide [23]. For the purposes of this comparison, 
we considered only the 4601 ICON patients who were 
admitted to ICUs in the same 24 European countries 
as in the SOAP study and had physiologic and ventila-
tion data recorded in the ICU (Fig.  1, Additional file  1: 
Table S1). For both studies, recruitment for participation 
was by open invitation and participation was voluntary. 
Institutional review board approval for both studies was 
obtained by the participating institutions according to 
local ethical regulations.
> 8 ml/kg PBW were independently associated with a higher risk of death. These data highlight the continued burden 
of ARDS and provide hypothesis‑generating data for the design of future studies.
Keywords: Respiratory failure, ARDS, Airway pressures, Driving pressure, Tidal volume, Mechanical ventilation
Fig. 1 Flow diagram showing patient inclusion
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Participating ICUs (see Additional file  1: e-Appendix) 
were asked to prospectively collect data on all adult 
patients admitted between May 1 and 15, 2002, for the 
SOAP study and between May 8 and 18, 2012, for the 
ICON audit. In both studies, patients who stayed in the 
ICU for < 24  h for routine postoperative surveillance 
were not included. Re-admissions of previously included 
patients were also not included.
Data collection
Data were collected daily during the ICU stay for a maxi-
mum of 28 days. Data collection on admission included 
demographic data and comorbid diseases as well as 
source and reason for admission. Clinical and laboratory 
data for the Simplified Acute Physiology Score II (SAPS 
II) [24] score were recorded as the worst values within 
24 h after admission. A daily evaluation of organ dysfunc-
tion/failure (cardiovascular, respiratory, renal, hepatic, 
coagulation, and central nervous systems) was performed 
using the sequential organ failure assessment (SOFA) 
score [25].
Values of tidal volume, PEEP, plateau pressure (Pplat) 
and fraction of inspired oxygen  (FiO2) corresponding 
to the most abnormal value of arterial  PO2  (PaO2) or 
arterial  O2 saturation  (SaO2) were recorded every 24  h; 
the mode of mechanical ventilation was not recorded. 
Patients were followed up for outcome data until death, 
hospital discharge or for 60 days.
Definitions
Patients were retrospectively identified as having ARDS 
requiring mechanical ventilation if they presented all the 
following: (a) severe hypoxemia, as defined by a  PaO2/
FiO2 ratio < 300  mmHg with a minimum of 5  cmH2O 
PEEP; (b) presence of bilateral lung infiltrates on the 
chest radiograph; (c) no evidence of pre-existing heart 
failure; (d) absence of chronic obstructive pulmonary dis-
ease (COPD) or other chronic pulmonary disorders; (e) 
invasive mechanical ventilation. The severity of ARDS 
was categorized according to the Berlin definitions into 
mild, moderate, and severe [6].
For calculation of tidal volume per predicted body 
weight (PBW), the average PBW of male patients was 
calculated as equal to 50 + [0.91 (height in centim-
eters—152.4)]; and that of female patients as equal to 
45.5 + [0.91 (height in centimeters—152.4)] [4]. We cal-
culated driving pressure as the difference between Pplat 
and PEEP. Due to the observational nature of the original 
studies [22, 23], the management of ARDS did not follow 
a predefined protocol.
Non-respiratory organ failure was defined as a SOFA 
score > 2 for the organ in question.
Outcome parameters
The primary outcome parameter was in-hospital mor-
tality within 60 days of admission to the ICU. Second-
ary outcome parameters included death in the ICU, 
ICU and hospital lengths of stay, and organ failure as 
assessed by the SOFA score.
Statistical analysis
All data were processed and analyzed in the Depart-
ment of Intensive Care of Erasme Hospital, University 
of Brussels, in collaboration with Jena University Hos-
pital, Jena, Germany. Data were analyzed using IBM® 
SPSS® Statistics software, v.21 for Windows (IBM, 
Somers, NY, USA). Data were reviewed for plausibil-
ity and availability of the outcome parameter, and any 
doubts were clarified with the center in question. There 
was no on-site monitoring. Missing data represented 
< 6% of the data collected for SOAP and 6.1% of the 
ICON data.
Data are summarized using means with standard 
deviation, medians and interquartile ranges, or num-
bers and percentages. Difference testing between 
groups was performed using Student’s t test, Mann–
Whitney test, Chi–square test or Fisher’s exact test, as 
appropriate. The Kolmogorov–Smirnov test was used, 
and histograms and quantile–quantile plots were exam-
ined to verify whether there were significant deviations 
from the normality assumption of continuous variables.
To evaluate the possible association between ventila-
tory parameters and outcome in patients with ARDS, 
we grouped the patients with ARDS from the SOAP 
study and ICON audit and performed a multivariable 
logistic regression analysis, with in-hospital death as 
the dependent variable. Covariates to be included in the 
final model were based on a univariate logistic regres-
sion analysis (p < 0.2) of demographic variables (age and 
sex), comorbid conditions, severity scores on admission 
to the ICU (SAPS II and SOFA scores), and severity 
of respiratory failure according to the  PaO2/FiO2 ratio 
on the first day of mechanical ventilation. Colinearity 
between variables was ruled out before covariates were 
introduced in the model. Goodness of fit was tested 
using a Hosmer and Lemeshow test, and odds ratios 
(OR) with 95% confidence interval (CI) were computed. 
As driving pressure, Pplat, and PEEP are mathemati-
cally linked and were confirmed to be colinear  (r2 > 0.6), 
we constructed separate logistic regression models for 
each parameter including the previously mentioned 
parameters. The multivariable models were adjusted 
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for tidal volume > 8  ml/kg PBW, respiratory rate, the 
country of origin and the study period (ICON audit vs. 
SOAP study).
No statistical adjustments were used for multi-
ple testing. All reported p values are two-sided and a 
p value < 0.05 was considered to indicate statistical 
significance.
Results
Temporal differences in the characteristics of patients 
with ARDS
The characteristics of the patients with ARDS included 
in the two cohorts are given in Table 1. The frequency of 
ARDS on admission to the ICU (5.1 vs. 5.0%, p = 0.866) 
and at any time during the ICU stay (10.4 vs. 10.7%, 
p = 0.793) was similar in the SOAP and ICON patients 
(Fig.  1). The diagnosis of ARDS was established at a 
median of 3 (IQ: 1–7) days after admission in the SOAP 
and 2 (IQ: 1–6) days in the ICON audit. Within 24 h of 
diagnosis, ARDS was mild in 244 (29.7%), moderate in 
388 (47.3%), and severe in 189 (23.0%) patients.
Patients with ARDS in the later period (ICON audit) 
were more commonly admitted to the ICU for medical 
reasons than after surgical interventions (Table 1) and 
had slightly higher SAPS II and SOFA scores on admis-
sion to the ICU than those with ARDS included in the 
earlier study (SOAP) (Table 1).
Mechanical ventilation
Ventilator settings in ARDS patients who required 
mechanical ventilation in the SOAP study and ICON 
audit are shown in Table 2. Respiratory rates were simi-
lar in the two cohorts. Tidal volumes were set at lower 
levels in the later (ICON) than in the earlier (SOAP) 
cohort (Fig.  2). Although the proportion of patients 
ventilated with protective tidal volumes (≤ 8  ml/kg) 
was higher in ICON than in SOAP (35.5% vs 18.0%, 
p < 0.001) and of patients ventilated with tidal vol-
umes associated with VILI (i.e., > 10 ml/kg) was lower 
(117/465 [25.2%] vs 151/322 [46.9%], p < 0.001), after 
10  years, more than 60% of patients with ARDS were 
still ventilated with tidal volumes greater than 8 ml/kg. 
PEEP was set at a slightly lower level in the ICON com-
pared to the SOAP, and Pplat and driving pressure were 
also lower in the ICON audit than in the SOAP study 
(Table 2 and Fig. 2).
Morbidity and mortality
The incidence of hepatic failure on admission to the 
ICU was higher and the incidence of renal failure lower 
in the ICON audit than in the SOAP study;  the overall 
prevalence of hepatic, renal, and cardiovascular organ 
failure during the ICU stay was higher in the ICON audit 
than the SOAP study (Additional file  1: Table  S2). ICU 
lengths of stay were similar in patients with ARDS in the 
two cohorts [median (IQ: 10 (5–21) vs. 9 (4–18) days, 
p = 0.257], whereas, hospital lengths of stay were longer 
in the SOAP study than ICON audit [median (IQ: 27 
(11–55) vs. 16 (7–34) days, p < 0.001]. Hospital mortality 
rates in patients with mild, moderate and severe ARDS 
were not significantly different between  the two studies 
(Additional file 1: Figure S1). Patients with severe ARDS 
within 24  h of diagnosis or at any time during the ICU 
stay had higher hospital mortality rates than those with 
Table 1 Characteristic of  patients with  acute respiratory 
distress syndrome (ARDS) on admission to the ICU
ARDS acute respiratory distress syndrome, ER emergency room, HIV human 
immunodeficiency virus, OR operating room, SAPS Simplified Acute Physiology 
Score, SOFA Sequential Organ Failure Assessment, SD standard deviation
SOAP study ICON audit p value
N 327 494
Age, years, mean ± SD 59 ± 17 61 ± 16 0.124
Male, n (%) 194 (59.3) 321 (65) 0.079
Referring facility, n (%) 0.016
 ER/ambulance 54 (18.5) 170 (34.4)
 Hospital floor 104 (35.6) 156 (31.6)
 OR/recovery room 77 (26.4) 72 (14.6)
 Other hospital 57 (19.5) 61 (12.3)
 Other – 35 (7.1)
Type of admission, n (%) < 0.001
 Medical admission 178 (54.4) 369 (74.7)
 Elective surgery 58 (17.7) 48 (9.7)
 Emergency surgery 91 (27.8) 77 (15.6)
Severity scores, mean ± SD
 SAPS II score 47.7 ± 17.6 51.2 ± 17.1 0.002
 SOFA score, total 7.9 ± 4.4 9.5 ± 4.1 < 0.001
Comorbidities, n (%)
 Non metastatic cancer 34 (10.4) 49 (9.9) 0.528
 Diabetes, insulin dependent 18 (5.5) 43 (8.7) 0.087
 Cirrhosis 11 (3.4) 26 (5.3) 0.199
 Metastatic cancer 9 (2.8) 21 (4.3) 0.442
 Hematologic cancer 19 (5.8) 25 (5.1) 0.641
 Chemotherapy 6 (1.8) 25 (5.1) 0.023
 HIV 0 (0) 8 (1.6) 0.025
Risk factors for ARDS, n (%)
 Shock, any cause 160 (48.9) 272 (55.1) 0.085
 Polytrauma 28 (8.6) 35 (7.1) 0.436
 Pancreatitis 12 (3.7) 17 (3.4) 0.862
 Near drowning 2 (0.6) 0 (0) 0.082
 Burns 2 (0.3) 0 (0) 0.219
 PaO2/FiO2, mean ± SD 164 ± 90 172 ± 108 0.920
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mild and moderate ARDS. However, hospital mortality 
rates were similar in patients with mild and moderate 
ARDS during the ICU stay (Additional file 1: Figure S1).
Predictors of worse outcome in patients with ARDS
In logistic regression analysis in all patients with ARDS 
from the two cohorts, with in-hospital death as the 
dependent variable, older age, greater SAPS II score, 
metastatic cancer, the presence of coagulation, renal and 
neurological system failures on admission to the ICU, 
and lower  PaO2/FiO2 were independently associated with 
a greater risk of in-hospital death. Pplat > 29  cmH2O and 
driving pressure > 14  cmH2O on the first day of mechani-
cal ventilation after establishing a diagnosis of ARDS, but 
not tidal volume > 8 ml/kg PBW or respiratory rate, were 
independently associated with a greater risk of death in 
these patients (Table 3).
Discussion
The main findings of our study are: (1) the frequency of 
ARDS in European ICUs did not change significantly 
from 2002 to 2012 and morbidity and mortality rates 
were similarly high; (2) ventilation with lower tidal vol-
umes and lower airway pressures (Pplat and driving pres-
sure) increased over time; and (3) Pplat > 29  cmH2O and 
driving pressure > 14  cmH2O on the first day of mechani-
cal ventilation but not tidal volume > 8 ml/kg PBW were 
independently associated with a higher risk of death in 
these patients.
In these two large European ICU cohorts [22, 23], per-
formed 10  years apart, the frequency of ARDS at any 
time during the ICU stay remained relatively constant 
over time at just over 10%. Bellani et al. [8] reported that 
10.4% of patients admitted to ICUs in 50 countries had 
ARDS during the ICU stay using the Berlin definitions 
[3]. Other studies [26–30] have reported a frequency of 
ARDS between 3 and 29%, varying according to the stud-
ied population and the definition used. Indeed, we pre-
viously reported that the frequency of ARDS was 12.6% 
from the SOAP study database [9] using the earlier 
European American Consensus criteria [2], which may 
overestimate the actual frequency of ARDS by including 
mild cases of respiratory dysfunction. Although we used 
the Berlin definitions to define ARDS [3], only patients 
requiring invasive mechanical ventilation were consid-
ered in our analysis due to the absence of precise data 
on non-invasive mechanical ventilation. Therefore, the 
overall frequency of ARDS in our study may have been 
slightly underestimated. Nonetheless, the same set of 
data were collected using similar protocols for the two 
cohorts [22, 23] and we only included data from patients 
admitted to ICUs in the same 24 countries.
Our data confirm the persistently high morbidity and 
mortality rates in patients with ARDS. Other studies have 
similarly reported mortality rates ranging from 40 to 60% 
in these patients [8, 31]. ARDS represents a major bur-
den to the healthcare system, making it an important tar-
get for research into how best to manage these patients 
Table 2 Ventilatory parameters within 24 h of meeting ARDS criteria on mechanical ventilation in the two cohorts
PBW predicted body weight, PEEP positive end-expiratory pressure, SD standard deviation
*Number of patients with recorded values, excluding missing values
† Valid percentage after excluding missing values
SOAP study ICON audit p value
n* n*
Respiratory rate, mean ± SD 24 ± 21 23 ± 10 0.129
Tidal volume, ml/kg PBW, mean ± SD 322 10.3 ± 2.8 465 9.0 ± 2.1 < 0.001
 < 6 ml/kg PBW, n (%)† 8 (2.5) 14 (3.0) 0.660
 6–8 ml/kg PBW, n (%)† 50 (15.5) 151 (32.5) < 0.001
 8.1–10 ml/kg PBW, n (%)† 113 (35.1) 183 (39.4) 0.225
 > 8 ml/kg PBW, n (%)† 264 (82.0) 300 (64.5) < 0.001
 > 10 ml/kg PBW, n (%)† 151 (46.9) 117 (25.2) < 0.001
PEEP,  cmH2O, mean ± SD 327 8.1 ± 3.4 494 7.6 ± 2.9 < 0.001
 5–9  cmH2O, n (%)
† 209 (63.9) 354 (71.7) 0.019
 10–14  cmH2O, n (%)
† 96 (29.4) 126 (25.5) 0.224
 ≥ 15  cmH2O, n (%)† 22 (6.7) 14 (2.8) 0.008
Plateau pressure,  cmH2O, mean ± SD 284 28.0 ± 7.5 396 23.5 ± 7.1 < 0.001
 > 29  cmH2O, n (%)
† 116 (40.8) 80 (20.2) < 0.001
Driving pressure,  cmH2O, mean ± SD 284 19.9 ± 7.1 396 16.1 ± 6.1 < 0.001
 > 14  cmH2O, n (%)
† 219 (77.1) 236 (59.6) < 0.001
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so as to improve outcomes. Despite increased adherence 
to a lung-protective strategy in mechanically ventilated 
patients with ARDS observed in the more recent ICON 
audit [23] compared to the earlier SOAP study [22], mor-
tality rates did not seem to have improved. Other factors 
may, therefore, have played a role in determining the out-
come in these patients. Indeed, we identified several fac-
tors, such as older age, greater SAPS II score, metastatic 
cancer, and the presence of coagulation, renal, and neu-
rologic organ failures on admission to the ICU as being 
independently associated with a greater risk of in-hospi-
tal death. These factors, reflecting the severity of illness 
and the degree of organ dysfunction in these patients on 
admission to the ICU, have been reported in previous 
studies [9, 10].
Although the proportion of ARDS patients ventilated 
with low tidal volume (≤ 8 ml/kg PBW) and low Pplat 
(≤ 29  cmH2O) was higher in the later ICON audit than 
in the early SOAP study, a considerable proportion of 
ARDS patients in both studies were not mechanically 
ventilated using lung protective settings. One possible 
explanation for this gap between best evidence and 
practice is that ARDS may not have been adequately 
recognized by the clinicians in the ICUs contributing to 
the SOAP study and ICON audit. Indeed, a large obser-
vational study in ICU patients in 50 countries reported 
that only 34% of clinicians recognized ARDS at the 
time of actual fulfillment of ARDS criteria as assessed 
by a computer algorithm from raw data, suggesting 
that diagnosis of ARDS is frequently delayed [8]. These 
authors [8] also reported that ARDS was underdiag-
nosed, with only 60% of all patients with ARDS being 
recognized by the clinician. We may also assume that 
use of pressure-controlled mechanical ventilation may 
lead to inevitable fluctuations in tidal volume with pos-
sible transitory increases above the required limit of 
8 ml/kg PBW. Calculation of tidal volume according to 
the actual weight rather than the PBW may also lead to 
erronously high tidal volume levels, especially in obese 
patients. Tidal volume > 8  ml/kg PBW on the first day 
of mechanical ventilation was not associated with the 
risk of death in patients with ARDS. This is perhaps not 
Fig. 2 Histograms with normality curves representing the tidal volumes, plateau pressures, and positive end‑expiratory pressures (PEEP) during 
mechanical ventilation in patients with acute respiratory distress syndrome (ARDS) in the SOAP and ICON studies
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so surprising because the increased use of lower tidal 
volumes in the ICON audit decreased the median tidal 
volume in patients with ARDS included in the analysis 
(9 ml/kg PBW), which may have masked the potentially 
deleterious effects of high tidal volume observed in our 
previous analysis on the SOAP study database [9]. Air-
way pressures were also generally low, which may have 
outweighed the possible deleterious effects of high tidal 
volume. Low tidal volume remains, therefore, a main 
stay of ventilator management for these patients as sup-
ported by the best available evidence [2].
Pplat > 29  cmH2O on the first day of mechanical ven-
tilation after establishing the diagnosis of ARDS was 
independently associated with the risk of death in these 
patients. Indeed, Pplat is an important determinant of 
lung overdistention [32] and a good indicator of lung 
stress [17], and higher levels are well correlated to the 
risk of barotrauma [33]. Therefore, limiting Pplat is a cru-
cial component of lung-protective ventilation.
We also observed a potentially deleterious influence of 
driving pressure > 14  cmH2O on outcome. Amato et  al. 
reported that driving pressure was the variable most 
strongly associated with mortality in a post-hoc analy-
sis of data from nine randomized controlled trials of 
mechanically ventilated patients with ARDS [21]. Driving 
pressure > 14  cmH2O was also reported to be associated 
with an increased risk of hospital mortality in patients 
with moderate and severe ARDS [8]. Another study 
showed that driving pressure was associated with risk of 
death in hypoxemic patients regardless of the results of 
the chest radiograph or the presence of ARDS [34].
Our study has some limitations. First, this was a post 
hoc analysis and ARDS was not a primary or secondary 
outcome in either of our cohorts, and was not prede-
fined in the SOAP or ICON surveys. The ventilation and 
physiologic parameters were recorded as the worst val-
ues during the day, so that baseline values at the onset of 
ARDS cannot be precisely determined. Nevertheless, the 
variables needed to define ARDS were collected prospec-
tively by the two studies. In addition, although the Berlin 
definition of ARDS [3] addressed some limitations of the 
earlier AECC definition [2], poor reliability of some crite-
ria may contribute to underrecognition by clinicians [35]. 
Second, the multivariable analysis is limited by the varia-
bles included and the effects of other non-reported varia-
bles cannot be excluded. However, we adjusted for a large 
number of factors that are known to influence outcomes 
in patients with ARDS. Third, a cause-effect relationship 
between the risk factors we reported and outcome can-
not be ascertained due to the observational nature of 
the study. In this context, our data can be considered as 
hypothesis-generating to help guide future RCTs on the 
subject. Fourth, colinearity between the various airway 
Table 3 Logistic regression analysis with in-hospital death 
as the dependent variable in patients with ARDS
Excluding 96 patients with missing values and adjusted for country and study 
cohort (SOAP vs. ICON). Covariate inclusion in the final models was based 
on a univariate logistic regression analysis (p < 0.2) within the categories 
demographic variables (age and sex), comorbid conditions, severity of 
respiratory failure according to the  PaO2/FiO2 ratio on the first day of mechanical 
ventilation, in addition to tidal volume and respiratory rate (Hosmer&Lemeshow 
goodness of fit Chi square: 5.49, p = 0.71; Nagelkerke’s  R2 = 0.285). Patients who 
were excluded from the multivariable analysis due to missing variables (n = 96) 
had similar severity of respiratory failure as assessed by the  PaO2/FiO2 ratio on 
the first day of mechanical ventilation and similar mortality rates compared to 
those who were included in the analysis
CI confidence interval, CNS central nervous system, ER emergency room, ICU 
intensive care unit, OR operating room, PBW predicted body weight; PEEP 
positive end-expiratory pressure, SAPS Simplified Acute Physiology Score
† Introduced alternately in different models due to colinearity. The displayed 
values refer to those considered in the model that included the PEEP as a 
covariate. Changes in the pressure parameters did not influence the significant 
p-values of the other covariates
Odds ratio (95% CI) p value
Age (per year) 1.04 (1.03–1.04) < 0.001
Male 0.81 (0.56–1.11) 0.235
SAPS II (per point) 1.04 (1.02–1.05) < 0.001
Referring facility – –
 ER/ambulance R NA
 Hospital floor 0.89 (0.56–1.41) 0.618
 OR/recovery room 0.72 (0.42–1.23) 0.618
 Other hospital 0.77 (0.43–1.36) 0.367
 Others 0.96 (0.39–2.34) 0.923
Comorbidities – –
 No cancer R NA
 Solid cancer, non‑metastatic 0.88 (0.49–1.56) 0.653
 Solid cancer, metastatic 2.90 (1.28–7.47) 0.027
 Cirrhosis 1.70 (0.70–4.11) 0.244
 Hematologic cancer 1.79 (0.75–4.23) 0.192
 Steroids 1.52 (0.73–3.16) 0.263
Polytrauma 0.47 (0.21–1.06) 0.263
Organ failure on admission to the ICU – –
 Coagulation 5.59 (2.74–11.41) < 0.001
 Hepatic 1.07 (0.58–1.97) 0.830
 CNS 1.68 (1.14–2.48) 0.008
 Renal 1.82 (1.20–2.76) 0.005
 Cardiovascular 1.06 (0.73–1.53) 0.771
PaO2/FiO2 (per 20 mmHg) 0.99 (0.94–0.99) < 0.001
Initial ventilatory settings – –
 Respiratory rate 1.01 (0.99–1.02) 0.863
 Tidal volume > 8.0 ml/kg PBW 0.68 (0.46–1.02) 0.157
 PEEP,  cmH2O
†
  5–9 R NA
  10–14 1.1 (0.66–1.81) 0.72
  ≥ 15 2.61 (0.56–12.19) 0.224
 Driving pressure > 14  cmH2O
† 1.64 (1.1–2.46) 0.016
 Plateau pressure > 29  cmH2O
† 1.04 (1.01–1.07) 0.006
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pressure parameters due to a mathematical link between 
these parameters precluded their inclusion in the same 
multivariable model. Finally, ventilatory parameters were 
recorded at a fixed time point and may have changed 
during the day. Reporting of these parameters also did 
not follow specific instructions to standardize the tim-
ing of measurements within the respiratory cycle and the 
possible effect of spontaneous breathing cannot be fully 
excluded due to the observational nature of the study.
Conclusion
The frequency of and outcome from ARDS remained 
unchanged between 2002 and 2012. The adoption of 
lower tidal volume in ARDS increased overtime and 
lower driving pressure and Pplat were observed in 
patients with ARDS included in the more recent ICON 
audit than in the earlier SOAP study. Pplat > 29  cmH2O 
and driving pressure > 14  cmH2O on the first day of 
mechanical ventilation, but not tidal volume  > 8 ml/kg 
PBW, were independently associated with a higher risk of 
death.
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